128940.KS

Hanmi Pharmaceutical Co., Ltd. [128940.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

128940.KS Stock Summary

Top 128940.KS Correlated Resources

128940.KS


Top 10 Correlated ETFs

128940.KS


Top 10 Correlated Stocks

128940.KS


In the News

128940.KS Financial details

Company Rating
Strong Buy
Market Cap
3262.84B
Income
80.78B
Revenue
1330.85B
Book val./share
72995.89
Cash/share
-
Dividend
-
Dividend %
-
Employees
2.12K
Optionable
No
Shortable
Yes
Earnings
26 Jan 2023
P/E
39.16
Forward P/E
-
PEG
0.68
P/S
2.38
P/B
3.62
P/C
-
P/FCF
14.92
Quick Ratio
-
Current Ratio
1.08
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
6.74K
EPS next Y
-
EPS next Q
-
EPS this Y
460.28%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.58%
Revenue last 5Y
5.59%
Revenue Q/Q
7.9%
EPS Q/Q
37.74%
-
-
-
-
SMA20
-9.21%
SMA50
-1.4%
SMA100
-12.35%
Inst Own
-
Inst Trans
-
ROA
4%
ROE
10%
ROC
0.12%
Gross Margin
53%
Oper. Margin
12%
Profit Margin
6%
Payout
-
Shs Outstand
12.45M
Shs Float
6.28M
-
-
-
-
Target Price
-
52W Range
219117.64-323039.22
52W High
-18.28%
52W Low
+20.48%
RSI
47.03
Rel Volume
1.1
Avg Volume
31.24K
Volume
34.45K
Perf Week
1.93%
Perf Month
-8.97%
Perf Quarter
-18.52%
Perf Half Y
-13.3%
-
-
-
-
Beta
0.752151
-
-
Volatility
4348.35%, 16592.5%
Prev Close
-2.94%
Price
264000
Change
-0.75%

128940.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
78.35K86.34K94.59K89.66K100.27K
Net income per share
5.17K2.12K4.43K996.75.59K
Operating cash flow per share
-5.38K2.21K1.06K12.63K16.83K
Free cash flow per share
-27.8K-15.74K-14.09K7.81K13.96K
Cash per share
12K8.39K9.18K12.34K17.65K
Book value per share
60.84K59.76K61.48K60.84K66.92K
Tangible book value per share
63.83K61.92K64.21K63.26K70.68K
Share holders equity per share
60.84K59.76K61.48K60.84K66.92K
Interest debt per share
41.62K55.29K74.45K68.93K64.41K
Market cap
6560.4B4773.54B3259.15B4505.47B2963.73B
Enterprise value
6989.38B5337.39B4004.6B5161.5B3510.77B
P/E ratio
108.55191.7862.54376.7344.22
Price to sales ratio
7.164.72.934.192.46
POCF ratio
-104.29183.72261.8529.7314.68
PFCF ratio
-20.17-25.77-19.6448.0917.69
P/B Ratio
9.226.794.56.173.69
PTB ratio
9.226.794.56.173.69
EV to sales
7.635.253.64.82.92
Enterprise value over EBITDA
71.7149.5626.3650.1118.01
EV to operating cash flow
-111.11205.42321.7434.0617.39
EV to free cash flow
-21.49-28.81-24.1355.0920.96
Earnings yield
0.010.010.0200.02
Free cash flow yield
-0.05-0.04-0.050.020.06
Debt to equity
0.280.590.760.550.38
Debt to assets
0.520.530.570.560.52
Net debt to EBITDA
4.45.244.916.372.81
Current ratio
1.031.31.41.151.08
Interest coverage
7.684.34.161.977.57
Income quality
-1.041.040.2412.673.01
Dividend Yield
00000
Payout ratio
00.360.110.680.09
Sales general and administrative to revenue
0.060.060.060.040.05
Research and developement to revenue
0.170.160.170.20.12
Intangibles to total assets
0.030.040.030.040.04
Capex to operating cash flow
4.17-8.13-14.33-0.38-0.17
Capex to revenue
-0.29-0.21-0.16-0.05-0.03
Capex to depreciation
-7.19-4.48-3.22-0.94-0.39
Stock based compensation to revenue
00000
Graham number
84.09K53.33K78.24K36.94K91.71K
ROIC
0.080.070.070.040.1
Return on tangible assets
0.040.020.030.010.04
Graham Net
-52.32K-57.74K-69.65K-62.33K-55.98K
Working capital
18.92B129.12B190.4B80.92B55.02B
Tangible asset value
746.72B728.57B756.02B759B848.09B
Net current asset value
-210.42B-337.86B-429.24B-435.76B-304.51B
Invested capital
0.670.91.181.10.94
Average receivables
00000
Average payables
39.39B38.34B34.86B32.21B37.52B
Average inventory
270.33B278.15B317.63B308.54B279.36B
Days sales outstanding
00000
Days payables outstanding
42.6934.1728.4523.7627.41
Days of inventory on hand
212.78190.36247.85227.54160.09
Receivables turnover
00000
Payables turnover
8.5510.6812.8315.3613.32
Inventory turnover
1.721.921.471.62.28
ROE
0.080.040.070.020.08
Capex per share
-22.42K-17.95K-15.15K-4.82K-2.87K

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
25.29K29.25K26.8K26.46K28.55K
Net income per share
1.95K1.46K1.63K1.54K2.12K
Operating cash flow per share
5.54K4.76K8.12K3.94K4.77K
Free cash flow per share
4.76K4.1K6.85K2.87K3.87K
Cash per share
17.39K17.67K000
Book value per share
65.71K67.01K68.23K69.97K73K
Tangible book value per share
69.23K70.78K78.98K81.2K85.05K
Share holders equity per share
65.71K67.01K68.23K69.97K73K
Interest debt per share
62.68K63.13K-283.37-300.47-307.86
Market cap
3230.54B3307.13B3283.16B3690.56B2743.96B
Enterprise value
3770.69B3854.17B3283.16B3690.56B2743.96B
P/E ratio
34.5147.3342.0650.0827.03
Price to sales ratio
10.669.4410.2211.648.02
POCF ratio
48.6357.9333.7678.1748.05
PFCF ratio
56.767.3439.98107.2859.24
P/B Ratio
4.14.124.024.43.14
PTB ratio
4.14.124.024.43.14
EV to sales
12.441110.2211.648.02
Enterprise value over EBITDA
69.0271.1165.26202.8196.96
EV to operating cash flow
56.7667.5133.7678.1748.05
EV to free cash flow
66.1878.4839.98107.2859.24
Earnings yield
0.010.010.0100.01
Free cash flow yield
0.020.010.030.010.02
Debt to equity
0.380.38000
Debt to assets
0.530.520.520.50.49
Net debt to EBITDA
9.8910.09000
Current ratio
1.071.081.071.061.08
Interest coverage
7.14215.16-12.03-8.77-12.69
Income quality
2.843.274.982.562.25
Dividend Yield
00000
Payout ratio
000.20.320.45
Sales general and administrative to revenue
0.050.060.410.420.41
Research and developement to revenue
0.120.12000
Intangibles to total assets
0.040.04000
Capex to operating cash flow
-0.14-0.14-0.16-0.27-0.19
Capex to revenue
-0.03-0.02-0.05-0.04-0.03
Capex to depreciation
-0.43-0.33-0.66-0.56-0.42
Stock based compensation to revenue
00000
Graham number
53.73K46.88K50K49.2K58.97K
ROIC
0.030.030.030.020.04
Return on tangible assets
0.010.010.010.010.01
Graham Net
-57.67K-56.05K-85.88K-80.73K-80.53K
Working capital
47.12B55.02B47.23B42.11B57.99B
Tangible asset value
829.6B848.09B000
Net current asset value
-335.75B-304.51B-302.45B-265.3B-220.27B
Invested capital
0.950.94000
Average receivables
00000
Average payables
00000
Average inventory
00000
Days sales outstanding
00000
Days payables outstanding
21.823.26000
Days of inventory on hand
179.03135.85000
Receivables turnover
00000
Payables turnover
4.133.87000
Inventory turnover
0.50.66000
ROE
0.030.020.020.020.03
Capex per share
-788.68-665.48-1.26K-1.07K-900.33

128940.KS Frequently Asked Questions

What is Hanmi Pharmaceutical Co., Ltd. stock symbol ?

Hanmi Pharmaceutical Co., Ltd. is a KR stock and trading under the symbol 128940.KS

What is Hanmi Pharmaceutical Co., Ltd. stock quote today ?

Hanmi Pharmaceutical Co., Ltd. stock price is $264000 today.

Is Hanmi Pharmaceutical Co., Ltd. stock public?

Yes, Hanmi Pharmaceutical Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap